"Etidronic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
| Descriptor ID |
D012968
|
| MeSH Number(s) |
D02.705.429.500.830
|
| Concept/Terms |
Etidronic Acid- Etidronic Acid
- (1-hydroxyethylene)diphosphonic acid
- Hydroxyethylidene Diphosphonic Acid
- Diphosphonic Acid, Hydroxyethylidene
Etidronate- Etidronate
- 1-Hydroxyethane-1,1-Diphosphonate
- 1 Hydroxyethane 1,1 Diphosphonate
- 1-Hydroxyethylidene-1,1-Bisphosphonate
- 1 Hydroxyethylidene 1,1 Bisphosphonate
- EHDP
- 1,1-hydroxyethylenediphosphonate
- 1,1 hydroxyethylenediphosphonate
- HEDP
- Hydroxyethanediphosphonate
- Ethanehydroxyphosphate
- Ethanehydroxydiphosphonate
Etidronate Disodium- Etidronate Disodium
- Phosphonic acid, (1-hydroxyethylidene)bis-, disodium salt
- Sodium Etidronate
- Etidronate, Sodium
- Disodium 1-Hydroxyethylene Diphosphonate
- 1-Hydroxyethylene Diphosphonate, Disodium
- Diphosphonate, Disodium 1-Hydroxyethylene
- Disodium 1 Hydroxyethylene Diphosphonate
- Disodium Etidronate
- Etidronate, Disodium
- HEDSPA
Etidronate, Tetrapotassium Salt- Etidronate, Tetrapotassium Salt
- Salt Etidronate, Tetrapotassium
- Tetrapotassium Salt Etidronate
- (1-hydroxyethylene)diphosphonic acid, Tetrapotassium Salt
|
Below are MeSH descriptors whose meaning is more general than "Etidronic Acid".
Below are MeSH descriptors whose meaning is more specific than "Etidronic Acid".
This graph shows the total number of publications written about "Etidronic Acid" by people in this website by year, and whether "Etidronic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Etidronic Acid" by people in Profiles.
-
Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2. Cell Rep. 2022 10 25; 41(4):111508.
-
Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial. Lancet Oncol. 2014 Dec; 15(13):1460-1468.
-
Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol. 2013 Oct; 108(10):1576-83.
-
Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism. J Bone Miner Metab. 2014 Mar; 32(2):151-8.
-
14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status. J Rheumatol. 2002 Sep; 29(9):1965-74.
-
What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig Dis Sci. 2002 Aug; 47(8):1665-78.
-
An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae. Am J Gastroenterol. 2000 Nov; 95(11):3112-7.
-
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. J Clin Endocrinol Metab. 1996 Mar; 81(3):961-7.